Molecule intelOpportunity: Moderate0Crowded market

Lumefantrine

390 brands · 217 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
37
Market saturation
100
Price room
100
Regulatory risk
50
390
brands
217
companies
Rs 608.25
median price
284
price points
14.16x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 2%

Price room

Across observed sources and strengths
CheapestRs 119.08
MedianRs 608.25
Most expensiveRs 1,685.64
Spread14.16×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 14.16x across 284 trusted points (Rs 119.08-1685.64). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Lumefantrine — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2024-04-28
Recall Alert; Drug Products: Artecid 75mg/3mL Injections by M/s Biolabs Pvt., Ltd., Islama

Why this score

Launch attractiveness

40% supply-gap(20) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

217 canonical companies and 390 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 14.16x across 284 trusted points (Rs 119.08-1685.64). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2024-04-28 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.